All extracted drugs
Showing 1–60 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Articles mentioning drugs
10,506 articles · page 33 of 876…by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated in a pha…
… tolerated dose (MTD) and/or recommended Phase 2 dose (RP2D) of BAL0891 monotherapy and combination with paclitaxel.Trial Registration …
… be enrolled in the first stage. If ≥2 patients respond to NIVO+RELA, the study will continue enrollment for a total of 20 patients.…
… blood samples collected from patients treated with monotherapy CX-801.Results PK analysis demonstrated dose-proportional exposure of …
…atezolizumab both as a single treatment and in combination with BNT314. In vivo, combining mPD-L1xmVEGF-A with hEpCAMxm4-1BB delayed o…
…n conjugated by non-releasable PEG. CD8a + T cells treated with IL-2 mutein conjugated by releasable PEG showed higher CTL activity …
…D-1 and CTLA-4, suggesting that tumor-secreted VEGF may amplify CT111 activity within the TME. These findings support clinical develo…
…arlatamab, epcoritamab, glofitamab, mosunetuzumab, talquetamab, teclistamab, and elranatamab. Eligibility criteria were abstracted for excl…
…ith larger tumors (~120 mm3) at the start of treatment, 5 mg/kg ANXV-chemo reduced tumor volume by 12.4% after one treatment. After two tr…
…the effectiveness and safety profiles of obinutuzumab (OBZ) and rituximab (RTX) in patients with NPSLE.Methods Patients with new-onset NP…
…in aberrant basaloid epithelial cells which have high levels of Keratin 17 (KRT17) and low levels of Keratin 5 (KRT5) although their sourc…